Figure 3From: Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools Tornado plots displaying sensitivity analysis (20% change) for TriVac model, PneumoADIP model and SUPREMES model for a hypothetical country in the sub-Saharan Africa (SSA) region using incremental cost-effectiveness ratio as an output. For PneumoADIP model, incremental cost-effectiveness ratio was not calculated because it was dominant strategy.Back to article page